CrushSCI.com
CrushSCI reveals real review times for each journal, giving authors transparent guidance for submission. As AI makes publishing increasingly challenging, the platform helps authors improve submission efficiency. Contact us if you need assistance.
Journal of Gynecologic Oncology journal cover Medicine
Back to journal directory

Review Cycle Records

Journal of Gynecologic Oncology

Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology and Colposcopy SCIE OA
2026 Emerging Zone 22025 CAS Zone 22026 JCR Q1
201.8Average days
207.5Median days
2Fastest days
452Longest days
1372025 publications

Paper Review Records

All Paper Review Records

12 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

370 days

LKB1 attenuates the transport activity of GLUT1 by regulating the alternative splicing of PKM1/PKM2 in cervical cancer

Authors
Mingzhe Wu; Yaoxing Guo; Jinghua Yang; Enhua Wang; Hong-Tao Xu; Guang-Ping Wu; Huanyu ZhaoShow moreShow less
Affiliations
1. Department of Gynecology, The First Hospital of China Medical University, Shenyang, China.; 2. Department of Pathology, The First Hospital and College of Basic Medical Sciences, China Medical University, Shenyang, China.Show moreShow less
Source PDF DOI Publisher page
81 days

Trastuzumab deruxtecan in HER2-expressing gynecologic cancers from DESTINY-PanTumor02: antitumor activity, safety, and exploratory biomarker analyses

Authors
Jung-Yun Lee; Ana Oaknin; Luis Manso; Antonio González-Martín; Iwona Ługowska; Domenica Lorusso; Susana Banerjee; John B. Liao; Chien-Hsing Lu; Naiyarat Prasongsook; Bohuslav Melichar; Chiedozie Anoka; Lindsey Jung; Flavia Michelini; Soham Puvvada; Funda Meric-Bernstam; Vicky MakkerShow moreShow less
Affiliations
1. Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.; 2. Medical Oncology Service, Vall d’Hebron Institute of Oncology, Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain.; 3. Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain.; 4. Medical Oncology Department and Programme in Solid Tumours CIMA, Cancer Center Clínica Universidad de Navarra, Madrid, Spain.; 5. Center for Excellence in Precision Medicine, Maria Skłodowska-Curie National Research Institute of Oncology, Warsaw, Poland.; 6. Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.; 7. Humanitas San Pio X, Milan, Italy.; 8. Gynaecology Unit, The Royal Marsden NHS Foundation Trust, London, UK.; 9. Institute of Cancer Research, London, UK.; 10. Division of Gynecologic Oncology, University of Washington, Seattle, WA, USA.; 11. Department of Obstetrics and Gynecology, Taichung Veterans General Hospital, Taichung, Taiwan.; 12. Division of Medical Oncology, Department of Medicine, Phramongkutklao Hospital, Bangkok, Thailand.; 13. Department of Oncology, Palacky University Medical School and University Hospital, Olomouc, Czech Republic.; 14. Global Medicines Development, Oncology R&D, AstraZeneca, Gaithersburg, MD, USA.; 15. Oncology Biometrics, Oncology R&D, AstraZeneca, Gaithersburg, MD, USA.; 16. Translational Medicine, Oncology R&D, AstraZeneca, Barcelona, Spain.; 17. Clinical Development, Late Oncology, Oncology R&D, AstraZeneca, Gaithersburg, MD, USA.; 18. Department of Investigational Cancer Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; 19. Gynecologic Medical Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; 20. Department of Medicine, Weill Cornell Medical College, New York, NY, USA.Show moreShow less
Source PDF DOI Publisher page
238 days

P16/Ki67 dual staining versus cytology for identifying high-grade cervical intraepithelial neoplasia (CIN2+/CIN3+) in triage management of HR-HPV-positive women: a systematic review and meta-analysis

Authors
Hang Zhou; Yu Dai; Hua Zhang; Yuan Yang; Ruoji Pi; Lingling Zhu; Wen ChenShow moreShow less
Affiliations
1. Department of Cancer Epidemiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.; 2. The State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health, Xiamen University, Xiamen, China.; 3. Mianyang Maternal and Child Health Care Hospital, Mianyang, China.Show moreShow less
Source PDF DOI Publisher page
452 days

Enhanced ovarian cancer diagnosis using deep learning on pelvic ultrasound with integrated clinical data: retrospective multicenter study

Authors
Sohyeon Jeong; Hyewon Cho; Jooyeon Kim; Sanghoon Lee; Jae Yun Song; Jin Hwa Hong; Jae Kwan Lee; Seon Kyung Kim; Hyun-Woong ChoShow moreShow less
Affiliations
1. Department of Obstetrics and Gynecology, Korea University Guro Hospital, College of Medicine, Korea University, Seoul, Korea.; 2. Department of Obstetrics and Gynecology, Korea University Anam Hospital, College of Medicine, Korea University, Seoul, Korea.; 3. Department of R&D, Aemasue Corp., Seoul, Korea.; 4. Department of Obstetrics and Gynecology, Asan Medical Center, Seoul, Korea.Show moreShow less
Source PDF DOI Publisher page
193 days

Diagnostic accuracy of the droplet digital PCR POLE mutation test in endometrial cancer: comparison with Sanger sequencing and NGS

Authors
Yung-Taek Ouh; Hyun-Woong Cho; Kyung-Jin Min; Jae-Kwan Lee; Yikyeong Chun; Jin Hwa HongShow moreShow less
Affiliations
1. Department of Obstetrics & Gynecology, Korea University Ansan Hospital, Ansan, Korea.; 2. Department of Obstetrics & Gynecology, Korea University Guro Hospital, Seoul, Korea.; 3. Department of Pathology, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea.Show moreShow less
Source PDF DOI Publisher page
2 days

Clinical practice guideline for high-risk human papillomavirus testing in cervical cancer screening: a consensus statement from the Korean Society of Gynecologic Oncology

Authors
Ju-Hyun Kim; Seung-Hyuk Shim; Kyung-Jin Min; Jae-Kwan Lee; Chong Woo Yoo; Min-Jung Kwon; Shin-Wha Lee; Jaeman BaeShow moreShow less
Affiliations
1. Department of Obstetrics and Gynecology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.; 2. Department of Obstetrics and Gynecology, Research Institute of Medical Science, Konkuk University School of Medicine, Seoul, Korea.; 3. Department of Obstetrics and Gynecology, Korea University Ansan Hospital, Ansan, Korea.; 4. Department of Obstetrics and Gynecology, Korea University Guro Hospital, Seoul, Korea.; 5. Department of Pathology, National Cancer Center, Goyang, Korea.; 6. Department of Laboratory Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.; 7. Department of Obstetrics and Gynecology, Hanyang University Medical Center, Seoul, Korea.Show moreShow less
Source PDF DOI Publisher page

FAQ

How long does Journal of Gynecologic Oncology take to review a manuscript?

As of 2026-11-19, CrushSCI has 12 complete review records for Journal of Gynecologic Oncology. The fastest paper went from submission to acceptance in 2 days (Clinical practice guideline for high-risk human papillomavirus testing in cervical cancer screening: a consensus statement from the Korean Society of Gynecologic Oncology, received 2026-01-29, accepted 2026-01-31); the slowest took 452 days. The average is 201.8 days and the median is 207.5 days. The fastest record has an unusually short interval; please check the original source.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.